Publication: AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Cold Spring Harbor Laboratory Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Morton, Sarah U., Sanjay P. Prabhu, Hart G.W. Lidov, Jiahai Shi, Irina Anselm, Catherine A. Brownstein, Matthew N. Bainbridge, Alan H. Beggs, Sara O. Vargas, and Pankaj B. Agrawal. 2017. “AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant.” Cold Spring Harbor Molecular Case Studies 3 (2): a001560. doi:10.1101/mcs.a001560. http://dx.doi.org/10.1101/mcs.a001560.
Research Data
Abstract
Apoptosis-inducing factor mitochondrion-associated 1 (AIFM1), encoded by the gene AIFM1, has roles in electron transport, apoptosis, ferredoxin metabolism, reactive oxygen species generation, and immune system regulation. Here we describe a patient with a novel AIFM1 variant presenting unusually early in life with mitochondrial disease, rapid deterioration, and death. Autopsy, at the age of 4 mo, revealed features of mitochondrial encephalopathy, myopathy, and involvement of peripheral nerves with axonal degeneration. In addition, there was microvesicular steatosis in the liver, thymic noninvolution, follicular bronchiolitis, and pulmonary arterial medial hypertrophy. This report adds to the clinical and pathological spectrum of disease related to AIFM1 mutations and provides insights into the role of AIFM1 in cellular function.
Description
Other Available Sources
Keywords
brain atrophy, congenital lactic acidosis, elevated brain lactate level by MRS, infantile encephalopathy, lethal infantile mitochondrial myopathy, mitochondrial encephalopathy
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service